Mirco J. Friedrich (@mircoscopy) 's Twitter Profile
Mirco J. Friedrich

@mircoscopy

Physician Scientist | Feng Zhang Lab @broadinstitute & @MIT | @EMBO Fellow
Decoding and engineering human immunity | 🇩🇪🇫🇷🇪🇺🇺🇸

ID: 1633663960636334081

calendar_today09-03-2023 03:00:31

74 Tweet

435 Takipçi

97 Takip Edilen

Waggoner Lab (@labwaggoner) 's Twitter Profile Photo

B7H6 protein flags activated T cells for clearance by NK cells, and its genetic deletion enhances T cell proliferation and persistence Science Immunology @platten_michael science.org/doi/10.1126/sc…

Science Immunology (@sciimmunology) 's Twitter Profile Photo

Science #Immunology’s May issue is out! This month’s cover depicts an NK cell (light blue) decorated with NKp30 (blue surface receptor) killing an antitumoral T cell (yellow) that expresses B7H6 (orange surface ligand). scim.ag/6YK

Science #Immunology’s May issue is out!
 
This month’s cover depicts an NK cell (light blue) decorated with NKp30 (blue surface receptor) killing an antitumoral T cell (yellow) that expresses B7H6 (orange surface ligand). scim.ag/6YK
EMBL-EBI Jobs (@emblebijobs) 's Twitter Profile Photo

Apply as a research group leader! Lead an independent research group in computational biology, focusing on AI-biology interfaces. Enjoy core support and outstanding infrastructure. Explore EMBL's Molecules to Ecosystems vision, and more! embl.org/jobs/position/…

SciStories LLC (@teamscistories) 's Twitter Profile Photo

Congrats to clients Mirco J. Friedrich, Michael Kilian, Kevin Lu, & @platten_michael for “The Immunoglobulin Superfamily Ligand B7H6 Subjects T Cell Responses To NK Cell Surveillance” in Science Immunology. Our work didn’t win the cover, but we loved it & wanted to share! #scienceillustration

Congrats to clients <a href="/mircoscopy/">Mirco J. Friedrich</a>, <a href="/MiKilian90/">Michael Kilian</a>, Kevin Lu, &amp; @platten_michael for “The Immunoglobulin Superfamily Ligand B7H6 Subjects T Cell Responses To NK Cell Surveillance” in <a href="/SciImmunology/">Science Immunology</a>. Our work didn’t win the cover, but we loved it &amp; wanted to share! #scienceillustration
Mirco J. Friedrich (@mircoscopy) 's Twitter Profile Photo

Honored to receive this Young Investigator Award for novel immunotherapy approaches against brain tumors. Thanks so much to my graduate institutes DKFZ and Universitätsklinikum Heidelberg for their support! 🎉 #brain #cancer #glioma #immunotherapy

Mirco J. Friedrich (@mircoscopy) 's Twitter Profile Photo

Happy to have contributed to this intelligent next step in building better mRNAs for therapeutic application! Check it out: nature.com/articles/s4158…

Rumya (@rumya_r) 's Twitter Profile Photo

1/ Thrilled to share an advancement in gene therapy from my PhD in Nature Communications! We've developed a new approach to reduce immune responses while maintaining efficiency—paving the way for safer, more effective therapies. Big thanks to Feng Zhang & Mirco J. Friedrich! bit.ly/redicas9

1/ Thrilled to share an advancement in gene therapy from my PhD in <a href="/NatureComms/">Nature Communications</a>! We've developed a new approach to reduce immune responses while maintaining efficiency—paving the way for safer, more effective therapies. Big thanks to <a href="/zhangf/">Feng Zhang</a> &amp; <a href="/mircoscopy/">Mirco J. Friedrich</a>! bit.ly/redicas9
Broad Institute (@broadinstitute) 's Twitter Profile Photo

Nucleases, core components of CRISPR-based genome-editing therapies, can stimulate unwanted immune responses. Scientists have now engineered two CRISPR nucleases to mask them from the immune system, paving the way for safer, more efficient gene therapies. broad.io/Nucleases-CRIS…

Nucleases, core components of CRISPR-based genome-editing therapies, can stimulate unwanted immune responses. Scientists have now engineered two CRISPR nucleases to mask them from the immune system, paving the way for safer, more efficient gene therapies. broad.io/Nucleases-CRIS…
Heidelberg Myeloma (@hdmyeloma) 's Twitter Profile Photo

📣 We are excited to announce the 10th Heidelberg Myeloma Workshop   Join us on April 25–26, 2025, as international & local experts share the latest advancements in multiple myeloma research. #mmsm ✅ CME-certified 🔗 Speaker line-up & registration 👇🏼 myelomaworkshop.de

📣 We are excited to announce the 10th Heidelberg Myeloma Workshop
 
Join us on April 25–26, 2025, as international &amp; local experts share the latest advancements in multiple myeloma research.
#mmsm 

✅ CME-certified
🔗 Speaker line-up &amp; registration 👇🏼
myelomaworkshop.de
HI-STEM - Cancer and Stem Cells in Heidelberg (@hi_stem_lab) 's Twitter Profile Photo

Congratulations to HI-STEM Group Leader Mirco Friedrich for being selected to the Forbes "30 under 30 Europe" List in the category of Science & Healthcare. forbes.com/profile/mirco-…

DKFZ (@dkfz) 's Twitter Profile Photo

Mirco Julian Friedrich vom DKFZ, HI-STEM - Cancer and Stem Cells in Heidelberg und Universitätsklinikum Heidelberg wurde in die renommierte Forbes-Liste "30 Under 30 Europe" in der Kategorie #Science & #Healthcare aufgenommen. Herzlichen Glückwunsch! 👏🥳 ➡️ t1p.de/lijrw

Mirco Julian Friedrich vom DKFZ, <a href="/hi_stem_lab/">HI-STEM - Cancer and Stem Cells in Heidelberg</a> und <a href="/uniklinik_hd/">Universitätsklinikum Heidelberg</a> wurde in die renommierte <a href="/Forbes/">Forbes</a>-Liste "30 Under 30 Europe" in der Kategorie #Science &amp; #Healthcare aufgenommen. Herzlichen Glückwunsch! 👏🥳
➡️ t1p.de/lijrw